Recruitment of p300/CBP in p53-dependent signal pathways

Cell

Volumn 89, Issue 7, 1997, Pages 1175-1184

  Avantaggiati, Maria Laura ^a,e   Ogryzko, Vasily ^b   Gardner, Kevin ^a   Giordano, Antonio ^d   Levine, Arthur S ^c   Kelly, Kathleen ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREBBP PROTEIN, HUMAN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN P53; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DIVISION; CELL LINE; CERCOPITHECUS; CYTOLOGY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; HUMAN; KIDNEY; METABOLISM; MUTAGENESIS; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE; CERCOPITHECUS AETHIOPS; CREB-BINDING PROTEIN; G1 PHASE; HUMANS; KIDNEY; MUTAGENESIS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031587821     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80304-9     Document Type: Article

References (35)

1. Angel, P., and Karin, M. (1991). The role of Jun, Fos and the AP1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta 1072, 129-157.
2. Arias, J., Alberts, A.S., Brindle, P., Claret, X.S., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994). Activation of cAMP and mitogen responsive genes relies on a common nuclear factor. Nature 370, 226-229.
3. Avantaggiati, M.L., Carbone, M., Graessman, A., Nakatani, Y., Howard, B., and Levine, A.S. (1996). The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional coactivator p300. EMBO J. 15, 2236-2248.
4. Bannister, A.J., and Kouzarides, T. (1996). The CBP co-activator is a histone acetyltransferase. Nature 384, 641-643.
5. Bates, S., and Vousden, K.H. (1996). p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6, 12-18.
6. Borrow, J., Stanton, V.P., Jr., Andersen, J.M., Becher, R., Behm, F.G., Chaganti, R.S., Civin, G.I., Discteche, C., Dube, I., Frichauf, A.M., Horsman, D., Mitelman, F., Volinia, S., Watmore, A.E., and Housman, D.E. (1996). The translocation t(8;16) (p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genet. 14, 33-41.
7. Chen, K.V., Ueda, K., Pastan, I., and Gottesman, M.M. (1992). Modulation of activity of the promoter of the human MDR1 gene by ras and p53. Science 255, 459-462.
8. Deb, S., Jackson, C.T., Subler, M.A., and Martin, D.W. (1992). Modulation of cellular and viral promoters bu mutant human p53 proteins found in human tumors. J. Virol. 66, 6164-6170.
9. Eckner, R., Ludlow, J.W., Lill, N.L., Oldread, E., Arany, Z., Modjtahedi, N., DeCaprio, J.A., and Livingston, D.M. (1996a). Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 16, 3454-3464.
10. Eckner, R., Yao, T.P., Oldread, E., and Livingston, D.M. (1996b). Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10, 2478-2490.
11. Fan, S., Simth, M.L., Rivet, D.J., Duba, D., Zhan, Q., Kohn, K.W., and Fornace, A.J., Jr. (1995) Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifilline. Cancer Res. 55, 1649-1654.
12. Giordano, T., Howard, T., Coleman, J., Sakamoto, K., and Howard, B. (1991). Isolation of a population of transiently transfected quiescent and senescent cells by magnetic affinity cell sorting. Exp. Cell. Res. 192, 193-197.
13. Haffner, R., and Oren, M. (1995). Biochemical properties and biological effects of p53. Curr. Opin. Genet. Dev. 5, 84-90.
14. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K., and Oren, M. (1995). Induction of apoptosis in HeLa cells by transactivation-deficient p53. Genes Dev. 9, 2170-2183.
15. Hinds, P., Finlay, C., and Levine, A.J. (1989). Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63, 739-746.
16. Janknecht, R., and Hunter, T. (1996a). Transcription. A growing coactivator network. Nature 383, 22-23.
17. Janknecht, R., and Hunter, T. (1996b). Versatile molecular glue. Transcriptional control. Curr. Biol. 6, 951-954.
18. Jenkins, J.R., Chumakov, P., and Curie, G.A. (1985). The cellular oncogene p53 can be activated by mutagenesis. Nature 317, 816-817.
19. Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Kurokawa, R., Gloss, B., Lin, S.C., Heyman, R.A., Rose, D.W., and Glass, C.K. (1996). A CBP integrator complex mediates transcriptional activation and AP1 inhibition by nuclear receptors. Cell 85, 403-414.
20. Ko, L.J., and Prives, C. (1996). p53: puzzle and paradigm. Genes Dev. 10, 1054-1072.
21. Lee, J.S., See, R.H., Deng, T., and Shiw, Y. (1996). Adenovirus E1a down regulates cJun and JunB-mediated transcription by targeting their coactivator p300. Mol. Cell. Biol. 16, 4312-4326.
22. Levine, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
23. Lill, N.L., Tevethia, M.J., Eckner, R., Livingston, D.M., and Modjtahedi, N. (1997). p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71, 129-137.
24. Michalovitz, D., Halevy, O.,and Oren, M. (1990). Conditional inhibition of transformation and cell proliferation by a temperature sensitive mutant of p53. Cell 62, 671-680.
25. Miyashita, T., Kraiewsky, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B., and Reed, J.C. (1994). Tumor suppressor p53 is a regulator of bcl2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
26. Moran, E. (1993). DNA tumor virus transfroming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3, 63-70.
27. Muraoka, M., Konishi, M., Yanoshita, R., Tanaka, K., Shitara, N., Chong, J.M., Iwama, T., and Miyaki, M. (1996). p300 gene alterations in colorectal and gastric carcinomas. Oncogene 12, 1565-1569.
28. Murphy, M., Hunman, A., and Levine, A.J. (1996). Wild-type p53 negatively regulates the expression of a microtubule-associated protein. Genes Dev. 10, 2971-2980.
29. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B., and Nakatani, Y. (1996). The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953-959.
30. Perkins, N.D., Felzien, L.K., Betts, J.C., Leung, K., Beach, D., and Nabel, G.J. (1996). Regulation of NF-κB by cyclin dependent kinases associated with p300 coactivator. Science 275, 523-527.
31. Puri, L., Avantaggiati, M.L., Balsano, C., Sang, N., Giordano, A., Graessmann, A., and Levrero, M. (1997). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16, 369-383.
32. Shen, Y., and Shenk, T. (1994). Relief of p53-mediated transcriptional repression by the adenovirus E1B-19 kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA 91, 8940-8944.
33. Yaciuk, P., and Moran, E. (1991). Analysis with specific polyclonal antiserum indicates that the E1a-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol. Cell. Biol. 11, 5389-5397.
34. Yang, X.J., Ogryzko, V.V., Nishikawa, J., Howard, B.H., and Nakatani, Y. (1996). A p300/CBP associated factor that competes with the adenoviral oncoprotein E1a. Nature 382, 319-324.
35. Yuan, W., Condorelli, G., Caruso, M., Felsani, A., and Giordano, A. (1996). Human p300 protein is a coactivator for the transcription factor Myo D. J. Biol. Chem. 271, 9009-9013.